Sunrise Global Exim

A prescription medication containing Indapamide (1.5 mg) in a sustained-release (SR) or film-coated formulation. It belongs to the class of thiazide-like diuretics and is primarily used to manage high blood pressure (hypertension) and swelling (edema) associated with fluid retention

A prescription medication containing Indapamide (3 mg) in a standard-release or film-coated formulation. It belongs to the class of thiazide-like diuretics and is primarily used to manage high blood pressure (hypertension) and swelling (edema) associated with fluid retention. 

A specialized, low-dose formulation containing Naltrexone Hydrochloride (4.5 mg). While standard higher doses of naltrexone (50 mg) are indicated for alcohol and opioid dependence, the 4.5 mg strength is primarily utilized for its "low-dose naltrexone" (LDN) properties to manage chronic inflammatory and autoimmune conditions. 

A prescription combination medication containing Indapamide (1.5 mg) and Amlodipine (5 mg). It is used to treat hypertension (high blood pressure) when treatment with a single active ingredient is not sufficient. 

Naltrexone 50 mg Tablet is a prescription medication used in the management of substance use disorders, particularly alcohol dependence and opioid dependence. It is designed to help individuals reduce cravings and prevent relapse by blocking the pleasurable effects associated with alcohol and opioid use. Naltrexone plays an important role as part of a comprehensive treatment program that includes counseling, behavioral therapy, and psychosocial support.

Naltrexone is an opioid receptor antagonist that works by binding to opioid receptors in the brain without activating them. By blocking these receptors, Naltrexone prevents opioids from producing their euphoric and sedative effects. In the treatment of alcohol dependence, Naltrexone helps reduce the reinforcing effects of alcohol consumption, thereby decreasing the desire to drink and supporting long-term abstinence.

Naltrexone 50 mg Tablet is typically taken orally once daily, or as prescribed by a healthcare professional. The dosage and duration of treatment depend on the patient’s condition, treatment goals, and overall medical history. Before starting therapy, patients must be opioid-free for a sufficient period to avoid precipitating withdrawal symptoms. Regular medical supervision is essential during treatment to ensure safety and effectiveness.

This medication has been shown to significantly reduce relapse rates in individuals recovering from alcohol or opioid dependence. By diminishing cravings and blocking reward pathways, Naltrexone helps patients maintain better control over substance use and supports long-term recovery. It is not addictive and does not cause physical dependence, making it a valuable option in addiction treatment.

Naltrexone 50 mg is generally well tolerated when used as directed. Common side effects may include nausea, headache, dizziness, fatigue, nervousness, insomnia, and abdominal discomfort. These effects are usually mild and transient. In some cases, Naltrexone may cause elevations in liver enzymes, so regular monitoring of liver function is recommended. Patients should immediately inform their healthcare provider if they experience symptoms such as persistent abdominal pain, dark urine, or yellowing of the skin or eyes.

Caution should be exercised when using Naltrexone in patients with liver disease, kidney impairment, or a history of depression or suicidal thoughts. It may interact with certain medications, including opioid-containing pain relievers and cough medicines. Patients should inform their doctor about all medications they are currently taking to avoid potential interactions.

Naltrexone 50 mg Tablet should be stored in a cool, dry place away from moisture and direct sunlight. Keep out of reach of children. This medicine is available only by prescription and should be used strictly under medical supervision.

In conclusion, Naltrexone 50 mg Tablet is an effective and well-established treatment option for alcohol and opioid dependence. When used as part of a structured recovery program and under proper medical guidance, it helps reduce cravings, prevent relapse, and support individuals on their journey toward long-term sobriety and improved quality of life.

Low-Dose Naltrexone (LDN) Tablet refers to the use of naltrexone at much lower doses than its standard approved strength. While standard naltrexone is commonly prescribed at 50 mg for opioid or alcohol dependence, low-dose naltrexone is typically used in doses ranging from 0.5 mg to 4.5 mg. LDN is increasingly used as an off-label therapy for various chronic and autoimmune-related conditions under medical supervision.

Naltrexone works by temporarily blocking opioid receptors in the body. At low doses, this brief blockade is believed to stimulate the body to produce higher levels of endorphins and enkephalins, which are natural chemicals involved in pain control, immune regulation, and overall well-being. This rebound effect is thought to help modulate the immune system and reduce inflammation, which explains the growing interest in LDN for immune-related disorders.

Low-Dose Naltrexone is commonly used off-label in conditions such as multiple sclerosis (MS), fibromyalgia, chronic fatigue syndrome, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, and other autoimmune or inflammatory disorders. Some patients also report benefits in managing chronic pain, mood disorders, and certain neurological conditions. It is important to note that while many patients experience positive outcomes, research is still ongoing, and LDN is not officially approved for these uses.

LDN tablets are usually taken once daily, often at night, as this timing may enhance endorphin release during sleep. The dosage is typically started very low and gradually increased based on patient response and tolerance. Because low-dose formulations are not always commercially available, LDN tablets are often prepared by compounding pharmacies to achieve precise dosing.

Low-Dose Naltrexone is generally well tolerated. Common side effects are usually mild and temporary and may include vivid dreams, sleep disturbances, headache, nausea, fatigue, or mild anxiety during the initial days of treatment. These effects often resolve as the body adjusts to the medication. Unlike high-dose naltrexone, LDN does not usually cause significant liver toxicity when used appropriately.

LDN should not be used by patients currently taking opioid pain medications, as it can block opioid effects and trigger withdrawal symptoms. Caution is also advised in patients with liver disease or those who are pregnant or breastfeeding. Alcohol consumption should be discussed with a healthcare provider before starting therapy.

In conclusion, Low-Dose Naltrexone Tablet is an emerging therapeutic option that may offer immune-modulating and anti-inflammatory benefits for patients with chronic and autoimmune conditions. When prescribed and monitored by a qualified healthcare professional, LDN can be a safe and promising addition to long-term treatment strategies. Patients should always consult their doctor before starting LDN to ensure appropriate dosing, safety, and realistic expectations regarding outcomes.

 

Low-Dose Naltrexone (LDN) 3 mg Tablet is a specialized formulation of naltrexone used at much lower doses than the standard 50 mg strength. While conventional naltrexone is approved for the treatment of opioid and alcohol dependence, low-dose naltrexone is commonly prescribed off-label to support immune regulation, inflammation control, and chronic pain management under medical supervision.

Naltrexone works by temporarily blocking opioid receptors in the body. At a low dose such as 3 mg, this blockage is brief and mild. The body responds by increasing the natural production of endorphins and enkephalins, which are chemicals that help regulate pain, immune function, mood, and inflammation. This rebound effect is believed to improve immune balance and reduce abnormal inflammatory responses.

Low-Dose Naltrexone 3 mg is widely used off-label in patients with autoimmune and inflammatory conditions. These may include multiple sclerosis (MS), fibromyalgia, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, lupus, psoriasis, and chronic fatigue syndrome. Some patients also use LDN 3 mg to help manage chronic pain, neurological disorders, and certain mood-related symptoms. Although growing clinical evidence and patient experiences support its use, ongoing research continues to evaluate its full therapeutic potential.

LDN 3 mg tablets are usually taken once daily, most commonly at night, as nighttime dosing may better support the body’s natural endorphin rhythm. Treatment often begins at a lower dose and is gradually increased to 3 mg to minimize side effects. Because low-dose strengths are not always commercially available, LDN tablets are often prepared by licensed compounding pharmacies to ensure accurate dosing.

Low-Dose Naltrexone 3 mg is generally well tolerated. Mild and temporary side effects may include vivid dreams, sleep disturbances, headache, nausea, fatigue, dizziness, or mild anxiety during the initial days of treatment. These effects typically improve as the body adjusts. Unlike high-dose naltrexone, LDN is not commonly associated with liver toxicity when used correctly.

LDN 3 mg should not be used by individuals taking opioid medications, as it can block opioid effects and may cause withdrawal symptoms. Caution is advised for patients with liver disease, those who are pregnant or breastfeeding, or individuals with a history of sensitivity to naltrexone. Alcohol use should be discussed with a healthcare provider before starting therapy.

In conclusion, Low-Dose Naltrexone 3 mg Tablet is a promising off-label treatment option for patients seeking immune modulation, inflammation reduction, and improved symptom control in chronic and autoimmune conditions. When prescribed and monitored by a qualified healthcare professional, LDN 3 mg may offer meaningful benefits with a favorable safety profile. Patients should always consult their doctor to ensure appropriate dosing, safety, and realistic treatment expectations.

Low-Dose Naltrexone (LDN) 4.5 mg Tablet is a specialized formulation of naltrexone used at much lower doses than the standard 50 mg strength. While conventional naltrexone is approved for the treatment of opioid and alcohol dependence, low-dose naltrexone is commonly prescribed off-label for its potential immune-modulating, anti-inflammatory, and pain-regulating properties. The 4.5 mg dose is one of the most commonly used and well-studied strengths in low-dose therapy.

Naltrexone works by temporarily blocking opioid receptors in the body. At a low dose such as 4.5 mg, this blockage is brief and partial. In response, the body increases its production of endorphins and enkephalins, which are natural chemicals involved in pain control, immune system balance, mood regulation, and inflammation reduction. This rebound effect is believed to help normalize immune function and decrease chronic inflammation.

Low-Dose Naltrexone 4.5 mg is widely used off-label in patients with autoimmune and inflammatory disorders. Common conditions include multiple sclerosis (MS), fibromyalgia, chronic fatigue syndrome, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, lupus, psoriasis, and other immune-related conditions. Many patients also report benefits in managing chronic pain, neurological symptoms, and certain mood disorders. While ongoing research continues to explore its full potential, LDN has gained recognition for its favorable safety profile and patient-reported benefits.

LDN 4.5 mg is typically taken once daily, most often at bedtime. Night-time dosing is thought to align with the body’s natural endorphin release cycle, potentially enhancing therapeutic effects. Treatment usually begins with a lower dose and is gradually increased to 4.5 mg to reduce the risk of side effects. Because low-dose formulations are not always commercially available, LDN tablets are often prepared by licensed compounding pharmacies to ensure accurate dosing.

Low-Dose Naltrexone 4.5 mg is generally well tolerated. Mild and temporary side effects may include vivid dreams, sleep disturbances, headache, fatigue, nausea, or mild anxiety during the initial phase of treatment. These effects typically resolve as the body adjusts to the medication. Unlike high-dose naltrexone, LDN is not commonly associated with significant liver toxicity when used appropriately.

LDN 4.5 mg should not be used by individuals taking opioid-based medications, as it can block opioid effects and may trigger withdrawal symptoms. Caution is advised in patients with liver disease, during pregnancy or breastfeeding, or in those with known hypersensitivity to naltrexone. Alcohol consumption should be discussed with a healthcare provider before starting therapy.

In conclusion, Low-Dose Naltrexone 4.5 mg Tablet is a promising off-label therapy for individuals seeking immune regulation, inflammation control, and relief from chronic symptoms. When prescribed and monitored by a qualified healthcare professional, LDN 4.5 mg may offer meaningful benefits with a strong safety profile, making it a valuable option in long-term supportive care strategies.